Literature DB >> 23132330

Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction.

M Odette Gore1, Mahesh J Patel, Mikhail Kosiborod, Lori S Parsons, Amit Khera, James A de Lemos, William J Rogers, Eric D Peterson, John C Canto, Darren K McGuire.   

Abstract

BACKGROUND: Patients with diabetes mellitus (DM) are at high risk for mortality after myocardial infarction (MI). Despite an overall trend of reduced mortality after MI, the mortality gap between MI patients with and without DM did not decrease over time in previous analyses. We assessed recent trends in hospital mortality for patients with MI according to DM status. METHODS AND
RESULTS: We analyzed data from the National Registry of Myocardial Infarction, a contemporary registry of MI patients treated in 1964 hospitals, representing approximately one fourth of all US acute care hospitals. The study comprised 1734431 MI patients enrolled from 1994 to 2006, including 502315 (29%) with DM. Crude hospital mortality decreased in all patients between 1994 and 2006 but remained higher in patients with DM compared with those without DM throughout the study. The absolute difference in mortality between patients with and without DM significantly narrowed over time, from 15.6% versus 11.5% in 1994 to 8.0% versus 6.8% in 2006 (P<0.001 for DM × time interaction). The adjusted odds ratio for mortality associated with DM declined from 1.24 (95% confidence interval, 1.16-1.32) in 1994 to 1.08 (95% confidence interval, 0.99-1.19) in 2006 (P<0.001 for trend). The largest improvement in hospital mortality was observed in diabetic women (17.9% in 1994 versus 8.4% in 2006; P<0.001).
CONCLUSIONS: The hospital mortality gap between MI patients with and without DM narrowed significantly from 1994 to 2006, with the greatest improvement observed in women with DM.

Entities:  

Mesh:

Year:  2012        PMID: 23132330     DOI: 10.1161/CIRCOUTCOMES.112.965491

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  18 in total

1.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

2.  State-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.

Authors:  Dharam J Kumbhani; Steven P Marso; Carlos A Alvarez; Darren K McGuire
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-01

Review 3.  Implementation of management strategies for diabetes and hypertension: from local to global health in cardiovascular diseases.

Authors:  Gerald S Bloomfield; Tracy Y Wang; L Ebony Boulware; Robert M Califf; Adrian F Hernandez; Eric J Velazquez; Eric D Peterson; Jennifer S Li
Journal:  Glob Heart       Date:  2015-03

4.  Decade-long trends in the characteristics, management and hospital outcomes of diabetic patients with ST-segment elevation myocardial infarction.

Authors:  Mayra Tisminetzky; Samuel Joffe; David D McManus; Chad Darling; Joel M Gore; Jorge Yarzebski; Darleen Lessard; Robert J Goldberg
Journal:  Diab Vasc Dis Res       Date:  2014-03-11       Impact factor: 3.291

Review 5.  Assessing Cardiovascular Risk and Testing in Type 2 Diabetes.

Authors:  Anum Saeed; Christie M Ballantyne
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

6.  The impact of stage of chronic kidney disease on the outcomes of diabetics with acute myocardial infarction treated with percutaneous coronary intervention.

Authors:  Teodora Vichova; Jiri Knot; Jaroslav Ulman; Marek Maly; Zuzana Motovska
Journal:  Int Urol Nephrol       Date:  2016-03-19       Impact factor: 2.370

7.  Decade-long trends (1999-2009) in the characteristics, management, and hospital outcomes of patients hospitalized with acute myocardial infarction with prior diabetes and chronic kidney disease.

Authors:  Mayra Tisminetzky; David D McManus; Alon Dor; Ruben Miozzo; Jorge Yarzebski; Joel M Gore; Robert J Goldberg
Journal:  Int J Nephrol Renovasc Dis       Date:  2015-05-05

8.  National trends over one decade in hospitalization for acute myocardial infarction among Spanish adults with type 2 diabetes: cumulative incidence, outcomes and use of percutaneous coronary intervention.

Authors:  Ana Lopez-de-Andres; Rodrigo Jimenez-Garcia; Valentin Hernandez-Barrera; Isabel Jimenez-Trujillo; Carmen Gallardo-Pino; Angel Gil de Miguel; Pilar Carrasco-Garrido
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

9.  Sex dependent risk factors for mortality after myocardial infarction: individual patient data meta-analysis.

Authors:  Hanna M van Loo; Edwin R van den Heuvel; Robert A Schoevers; Matteo Anselmino; Robert M Carney; Johan Denollet; Frank Doyle; Kenneth E Freedland; Sherry L Grace; Seyed H Hosseini; Kapil Parakh; Louise Pilote; Chiara Rafanelli; Annelieke M Roest; Hiroshi Sato; Richard P Steeds; Ronald C Kessler; Peter de Jonge
Journal:  BMC Med       Date:  2014-12-17       Impact factor: 8.775

10.  Magnitude, treatment, and impact of diabetes mellitus in patients hospitalized with non-ST segment elevation myocardial infarction: A community-based study.

Authors:  Hamza H Awad; Mayra Tisminetzky; Diana Metry; David McManus; Jorge Yarzebski; Joel M Gore; Robert J Goldberg
Journal:  Diab Vasc Dis Res       Date:  2015-10-23       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.